Addiclenz - 43742-0165-1 - (Beta Vulgaris, Boldo, Chelidonium Majus, Petroselinum Sativum, Taraxacum Officinale, Arsenicum Album, Belladonna)

Alphabetical Index


Drug Information of Addiclenz

Product NDC: 43742-0165
Proprietary Name: Addiclenz
Non Proprietary Name: Beta Vulgaris, Boldo, Chelidonium Majus, Petroselinum Sativum, Taraxacum Officinale, Arsenicum Album, Belladonna
Active Ingredient(s): 12; 30; 12; 30; 3; 3; 12; 12; 30; 12; 12; 30; 30; 3; 3; 12; 30; 12; 30; 30; 3; 30; 12; 30    [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL & nbsp;   Beta Vulgaris, Boldo, Chelidonium Majus, Petroselinum Sativum, Taraxacum Officinale, Arsenicum Album, Belladonna
Administration Route(s): ORAL
Dosage Form(s): LIQUID
Coding System: National Drug Codes(NDC)

Labeler Information of Addiclenz

Product NDC: 43742-0165
Labeler Name: Deseret Biologicals, Inc.
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date: 20121113

Package Information of Addiclenz

Package NDC: 43742-0165-1
Package Description: 30 mL in 1 BOTTLE, DROPPER (43742-0165-1)

NDC Information of Addiclenz

NDC Code 43742-0165-1
Proprietary Name Addiclenz
Package Description 30 mL in 1 BOTTLE, DROPPER (43742-0165-1)
Product NDC 43742-0165
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name Beta Vulgaris, Boldo, Chelidonium Majus, Petroselinum Sativum, Taraxacum Officinale, Arsenicum Album, Belladonna
Dosage Form Name LIQUID
Route Name ORAL
Start Marketing Date 20121113
Marketing Category Name UNAPPROVED HOMEOPATHIC
Labeler Name Deseret Biologicals, Inc.
Substance Name ARSENIC TRIOXIDE; ASPARTAME; ATROPA BELLADONNA WHOLE; BENZALKONIUM CHLORIDE; BETA VULGARIS; CHELIDONIUM MAJUS; COBALT; COPPER; FORMALDEHYDE; IODINE; LYCOPODIUM CLAVATUM SPORE; METHYLENE CHLORIDE; METHYLPARABEN; PETROSELINUM CRISPUM; PEUMUS BOLDUS LEAF; PHOSPHORIC ACID; PROPYLPARABEN; SELENIUM; SODIUM BENZOATE; SODIUM CITRATE; TARAXACUM OFFICINALE; TITANIUM DIOXIDE; ZINC; ZINC OXIDE
Strength Number 12; 30; 12; 30; 3; 3; 12; 12; 30; 12; 12; 30; 30; 3; 3; 12; 30; 12; 30; 30; 3; 30; 12; 30
Strength Unit [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL
Pharmaceutical Classes Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Copper [Chemical/Ingredient],Copper-containing Intrauterine Device [EPC],Decreased Embryonic Implantation [PE],Decreased Sperm Motility [PE],Inhibit Ovum Fertilization [PE],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Standardized Chemical Allergen [EPC],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Standardized Chemical Allergen [EPC],Increased Histamine Release [PE],Cell-mediated Immunity [PE],Allergens [Chemical/Ingredient],Ammonium Ion Binding Activity [MoA],Nitrogen Binding Agent [EPC],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]

Complete Information of Addiclenz


General Information